ANRT 와 협약

Sep 10, 2015PRESS RELEASESHit 2022

MedPacto Inc. and ANRT have entered into a collaboration agreement for the development of novel biologics and monoclonal antibodies to develop drugs and diagnosis. The collaboration will focus on the discovery and development of first-in-class therapies and diagnosis tools. Under the terms of the agreement, Medpacto, Inc. will share the outcome from the collaboration with ANRT

Next TEW-7197 첫 용량 투여에서 안전성 확인, 용량증대 결정
Previous 임상1상 용량 증대 - 4번째 용량 시험